Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $69,255 | 27 | 51.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $46,520 | 28 | 34.9% |
| Travel and Lodging | $15,305 | 55 | 11.5% |
| Food and Beverage | $2,373 | 40 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $61,105 | 75 | $0 (2024) |
| Merck Sharp & Dohme LLC | $35,306 | 28 | $0 (2023) |
| GlaxoSmithKline, LLC. | $27,360 | 37 | $0 (2024) |
| Chiesi USA, Inc. | $4,200 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $3,109 | 6 | $0 (2024) |
| GENZYME CORPORATION | $2,313 | 2 | $0 (2024) |
| Amgen Inc. | $58.92 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,444 | 35 | GlaxoSmithKline, LLC. ($12,399) |
| 2023 | $48,298 | 56 | AstraZeneca Pharmaceuticals LP ($29,741) |
| 2022 | $23,362 | 18 | Merck Sharp & Dohme LLC ($12,505) |
| 2021 | $19,368 | 23 | AstraZeneca Pharmaceuticals LP ($15,053) |
| 2020 | $13,650 | 3 | GlaxoSmithKline, LLC. ($13,650) |
| 2019 | $1,330 | 15 | GlaxoSmithKline, LLC. ($1,311) |
All Payment Transactions
150 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $2,265.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $566.25 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Consulting Fee | Cash or cash equivalent | $188.75 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/06/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $2,265.00 | General |
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Respiratory | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Respiratory | ||||||
| 10/08/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.29 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,300.00 | General |
| Category: Respiratory | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Consulting Fee | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $460.50 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Travel and Lodging | In-kind items and services | $422.13 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $96.00 | General |
| Category: Respiratory | ||||||
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $60.61 | General |
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $54.66 | General |
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $49.99 | General |
| 08/17/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $44.41 | General |
| 08/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $110.28 | General |
| 08/16/2024 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $15.03 | General |
| 07/19/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $281.06 | General |
| 07/19/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $162.03 | General |
| 07/19/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 07/19/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | In-kind items and services | $31.02 | General |
| 06/17/2024 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $5,200.00 | General |
| 06/17/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $1,300.00 | General |
| 06/17/2024 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $325.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 2 | 29 | 55 | $31,624 | $8,351 |
| 2021 | 2 | 39 | 85 | $50,379 | $13,128 |
| 2020 | 1 | 20 | 39 | $26,025 | $7,020 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 18 | 40 | $27,844 | $7,096 | 25.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 11 | 15 | $3,780 | $1,255 | 33.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 27 | 73 | $50,127 | $13,046 | 26.0% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Facility | 2021 | 12 | 12 | $252.00 | $82.32 | 32.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 20 | 39 | $26,025 | $7,020 | 27.0% |
About Dr. Matthew Drake, M.D
Dr. Matthew Drake, M.D is a Internal Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2008. The National Provider Identifier (NPI) number assigned to this provider is 1245487875.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Drake, M.D has received a total of $133,453 in payments from pharmaceutical and medical device companies, with $27,444 received in 2024. These payments were reported across 150 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($69,255).
As a Medicare-enrolled provider, Drake has provided services to 88 Medicare beneficiaries, totaling 179 services with total Medicare billing of $28,498. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Pulmonary Disease
- Location Portland, OR
- Active Since 08/26/2008
- Last Updated 04/15/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1245487875
Products in Payments
- TEZSPIRE (Biological) $19,404
- FASENRA (Biological) $14,356
- NUCALA (Biological) $8,461
- DUPIXENT (Biological) $3,109
- AIRSUPRA (Drug) $2,282
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078